Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx (MDXG) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Mimedx (MDXG) over the last 13 years, with Q3 2025 value amounting to $6.1 million.

  • Mimedx's Tax Provisions rose 7229.6% to $6.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.9 million, marking a year-over-year increase of 15751.03%. This contributed to the annual value of $15.3 million for FY2024, which is 14155.84% up from last year.
  • According to the latest figures from Q3 2025, Mimedx's Tax Provisions is $6.1 million, which was up 7229.6% from $3.4 million recorded in Q2 2025.
  • Over the past 5 years, Mimedx's Tax Provisions peaked at $6.1 million during Q3 2025, and registered a low of -$37.4 million during Q4 2023.
  • Over the past 5 years, Mimedx's median Tax Provisions value was $63000.0 (recorded in 2022), while the average stood at -$525315.8.
  • In the last 5 years, Mimedx's Tax Provisions tumbled by 13358214.29% in 2023 and then soared by 766081.08% in 2024.
  • Mimedx's Tax Provisions (Quarter) stood at -$108000.0 in 2021, then soared by 125.93% to $28000.0 in 2022, then tumbled by 133582.14% to -$37.4 million in 2023, then skyrocketed by 110.2% to $3.8 million in 2024, then surged by 60.09% to $6.1 million in 2025.
  • Its Tax Provisions was $6.1 million in Q3 2025, compared to $3.4 million in Q2 2025 and $1.6 million in Q1 2025.